BREAKING NEWS: Johnson & Johnson’s long-awaited one-shot COVID-19 vaccine may require TWO doses, White House coronavirus advisor says
- Johnson & Johnson’s one-dose COVID-19 vaccine was hailed as a way to increase supply and more quickly vaccinate the U.S. population
- But on Thursday, Andy Slavitt, the White House senior advisor on COVID-19 response, said the company is testing the effectiveness of its shot with a booster
- It’s unclear whether this will delay the vaccine being approved by the U.S. Food and Drug Administration for emergency use authorization
Johnson & Johnson’s one-shot coronavirus vaccine may actually be two doses, the Biden administration said.
The vaccine, which was recently submitted to the U.S. Food and Drug Administration (FDA) for approval, was hailed as one of the most effective ways to help increase supply and bring President Joe Biden closer to his goal of 150 million shots in arms in the first 100 days of his term.
However, during a Washington Post Live event, Andy Slavitt, the White House senior advisor on COVID-19 response, say the company is currently testing the e effectiveness of its shot with a booster.
The news raises concerns that the U.S. may not be able to immunize enough of the population before the more contagious variants from the UK and South Africa become dominant in the U.S.
It’s unclear if this will delay FDA approval of the inoculation for emergency use authorization.
Johnson & Johnson’s one-shot coronavirus vaccine may actually be two doses, the Biden administration said on Thursday (file image)
This is a breaking news story and will be updated.